November 2023 Brief
Dear reader, welcome to your monthly cannabis brief. We discuss the Netherlands getting ready to launch the supply chain experiment in December, German legalisation delays and draft changes, Japan and Canada approving pharmaceutical cannabis products, and US rescheduling debates. Australian, UK and Brazilian medical markets remain highly dynamic with new entries, Germany, Portugal, Israel and […]
October 2023 Brief
We discuss effects of the war in the Israeli market, UK CBD regulatory changes, the future of the French medical scheme, and the legislative process in Germany. Canada celebrates 5 years of legalisation amidst sector consolidation, while momentum in the Australian and UK medical markets perseveres, and the Dutch recreational experiment readies for launch later this year. Studies on the ‘entourage effect‘ support greater effects of full-spectrum cannabis […]
September 2023 Brief
European rec legalisation, surge of private clinics and international markets teeming with activity. A continental-wide policy shift is underway spearheaded by German legalisation, as well as commercial supply chain models like that of the Netherlands. September has also seen an uptick of deals in the German and Australian medical markets, particularly in the telehealth and private clinic segments. New export milestones by Canada, Uruguay, Portugal and New Zealand reflect on […]
August 2023 Brief
Revamping of regulations, mixed news for the CBD sector and launches of new medical cannabis products. August has seen a revamping of cannabis regulations in Israel and Argentina, and positive signs for the federal status of cannabis in the US and Germany. Israel will legalise over-the-counter CBD, while Italy, Portugal and Brazil tighten up rules for CBD market […]
July 2023 Brief
Market consolidation perseveres, regulatory roll-out intensifies. July has been a particularly productive month in the regulatory front with Germany, Ukraine, Brazil, Albania, New Zealand and Ghana announcing legal changes. The cannabis market is in the midst of a major consolidation: M&A, cost-cutting initiatives and facility closures have become a normal occurrence in 2023, and July has seen an […]